Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × Electrochemotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 2 Melanoma 2 Liver Metastases 2 Breast Neoplasms 2 Ulcer 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Neoplastic Processes 1 Neoplasms 1 Neoplasm Metastasis 1 Melanoma, Cutaneous Malignant 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Breast Cancer Female 1

Interventions

Sorafenib 62 Bevacizumab 37 Oxaliplatin 25 Fluorouracil 21 Doxorubicin 19 Gemcitabine 18 durvalumab 17 Nivolumab 17 pembrolizumab 16 Radiosurgery 16 Radiofrequency Ablation 16 Cisplatin 16 lenvatinib 15 Leucovorin 14 Capecitabine 14 atezolizumab 12 Hepatectomy 12 Radiotherapy 11 tremelimumab 10 Irinotecan 10 Cyclophosphamide 10 Carboplatin 9 Blood Specimen Collection 9 Liver Transplantation 8 Ipilimumab 8 Drug Therapy 8 Cryosurgery 8 Chemotherapy, Adjuvant 8 fludarabine 7 Melphalan 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed

25 enrolled 6 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡